Analysis in mechanism of Taohong Siwu Decoction in the treatment of femoral head necrosis based on network pharmacology

WANG Lei; CHEN Kun

doi:10.7619/jcmp.20200915

Journal of Clinical Medicine in Practice > 2021 > 25(2): 10-15,19. > DOI: 10.7619/jcmp.20200915

WANG Lei, CHEN Kun. Analysis in mechanism of Taohong Siwu Decoction in the treatment of femoral head necrosis based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 10-15,19. DOI: 10.7619/jcmp.20200915

Citation:

PDF (6146 KB)

Analysis in mechanism of Taohong Siwu Decoction in the treatment of femoral head necrosis based on network pharmacology

WANG Lei,
CHEN Kun^,

Department of Orthopedic Disease, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi, 712000

More Information

Received Date: September 21, 2020
Available Online: January 26, 2021
Published Date: January 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the mechanism of Taohong Siwu Decoction in the treatment of femoral head necrosis by means of network pharmacology method.
Methods Through Traditional Chinese Medicine Systems Pharmacology (TCMSP), GeneCards, OMIM and Drugbank databases, the active components and targets of Taohong Siwu Decoction in the treatment of osteonecrosis of femoral head were obtained, and then the active component-target interaction network, protein-protein Interaction(PPI)network and molecular docking were constructed. Finally, GO enrichment and KEGG pathway enrichment analysis were performed.
Results Sixty-nine active ingredients were screened from Taohong Siwu Decoction. The main active ingredients for femoral head necrosis were quercetin, kaempferol, and luteolin; the key targets were vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) and runt-related transcription factor 2 (Runx2). Through molecular docking server analysis, it was found that the active components of Taohong Siwu Decoction could bind closely to the key targets. GO enrichment analysis showed that the molecular functions mainly included transcription factor binding, steroid hormone receptor activity, protein kinase binding and so on. Biological processes mainly involved cytokine mediated signaling pathways, response to steroid hormones, apoptosis signaling pathways and other biological processes. Cell components mainly included nuclear transcription factor complex, protein kinase complex, protein-DNA complex and so on. KEGG enrichment analysis revealed that VEGF, Janus kinase/signal transduction and transcriptional activator (JAK/STAT) as well as nuclear transcription factor-kappa B (NF-κB) signaling pathways were involved.
Conclusion Taking VEGF, IL-6 and Runx2 as targets, the action mechanism of active ingredients of Taohong Siwu Decoction including quercetin, kaempferol, luteolin and so is to participate in VEGF, JAK/STAT and NF-κB signaling pathways in treatment of femoral head necrosis.
- Taohong Siwu Decoction,
- network pharmacology,
- femoral head necrosis,
- molecular docking,
- action mechanism

FullText(HTML)

References (25)

References

[1]	尹啸飞, 周正新. 中医药治疗股骨头坏死临床研究进展[J]. 辽宁中医药大学学报, 2018, 20(2): 218-221. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201802076.htm
[2]	张有为, 杨军琪, 李小宏. 身痛逐瘀汤治疗对股骨头坏死患者血液流变学的影响[J]. 世界中医药, 2019, 14(1): 154-157. doi: 10.3969/j.issn.1673-7202.2019.01.031
[3]	林智军, 李玉茂, 谢晓勇, 等. 桃红四物汤加减治疗对气滞血瘀型股骨头坏死骨修复及血液流变学的影响[J]. 世界中医药, 2018, 13(1): 105-108. doi: 10.3969/j.issn.1673-7202.2018.01.026
[4]	徐辉辉, 李索咪, 范梦强, 等. 富血小板血浆联合桃红四物汤对激素性股骨头坏死大鼠股骨头组织VEGF、CD31、ALP、β-catenin蛋白表达的影响[J]. 中华中医药杂志, 2020, 35(3): 1501-1504. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202003120.htm
[5]	姚金龙, 冯海波, 孙绍裘. 桃红四物汤治疗创伤性股骨头坏死临床疗效的观察[J]. 中国医药科学, 2019, 9(21): 9-12, 59. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX201921005.htm
[6]	潘祥龙, 郝二伟, 谢金玲, 等. 活血化瘀中药调节血瘀证的分子机制研究进展[J]. 中国实验方剂学杂志, 2018, 24(24): 227-234. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201824036.htm
[7]	杨凯麟, 曾柳庭, 葛安琪, 等. 基于网络药理学探讨桃仁-红花药对活血化瘀的分子机制[J]. 世界科学技术-中医药现代化, 2018, 20(12): 2208-2216. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX201812021.htm
[8]	CHOI J H, PARK S E, KIM S J, et al. Kaempferol inhibits thrombosis and platelet activation[J]. Biochimie, 2015, 115: 177-186. doi: 10.1016/j.biochi.2015.06.001
[9]	WANG S B, JANG J Y, CHAE Y H, et al. Kaempferol suppresses collagen-induced platelet activation by inhibiting NADPH oxidase and protecting SHP-2 from oxidative inactivation[J]. Free Radic Biol Med, 2015, 83: 41-53. doi: 10.1016/j.freeradbiomed.2015.01.018
[10]	CHOI J H, KIM K J, KIM S. Comparative effect of quercetin and quercetin-3-O-β-d-glucoside on fibrin polymers, blood clots, and in rodent models[J]. J Biochem Mol Toxicol, 2016, 30(11): 548-558. doi: 10.1002/jbt.21822
[11]	HUBBARD G P, WOLFFRAM S, LOVEGROVE J A, et al. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans[J]. J Thromb Haemost, 2004, 2(12): 2138-2145. doi: 10.1111/j.1538-7836.2004.01067.x
[12]	沈瑞明, 马丽辉, 郑颜萍. 木犀草素通过TLR/MyD88/NF-κB通路参与急性痛风性关节炎大鼠的抗炎作用[J]. 中南大学学报: 医学版, 2020, 45(2): 115-122. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYD202002003.htm
[13]	毕文慧, 刘暘. VEGF在类风湿关节炎发生、发展及治疗中的研究进展[J]. 内蒙古医科大学学报, 2019, 41(2): 211-214. https://www.cnki.com.cn/Article/CJFDTOTAL-NMYX201902030.htm
[14]	CHEN Y, MATHY N W, LU H. The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with nonsmall cell lung cancer (Review)[J]. Mol Med Rep, 2018, 17(6): 8019-8030. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983970/
[15]	HANG D, WANG Q, GUO C, et al. Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs[J]. Cells Tissues Organs, 2012, 195(6): 495-506. doi: 10.1159/000329502
[16]	苗丽, 张晨亮, 李欣, 等. 间充质干细胞成骨和成脂分化调控机制研究[J]. 药物评价研究, 2020, 43(12): 2363-2371. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ202012001.htm
[17]	张萌萌, 张秀珍, 邓伟民, 等. 骨代谢生化指标临床应用专家共识(2020)[J]. 中国骨质疏松杂志, 2020, 26(6): 781-796. doi: 10.3969/j.issn.1006-7108.2020.06.001
[18]	洪郭驹, 魏秋实, 韩晓蕊, 等. 祛痰逐瘀方经miR-628/Pten/Runx2调控酒精性股骨头坏死骨稳态代谢机制研究[J]. 广东医学, 2019, 40(2): 185-190. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201902007.htm
[19]	YUAN L, LI W, TIAN Z B, et al. Predictive role of cytokines IL-10, IL-12 and TNF-α gene polymorphisms for the development of osteonecrosis of the femoral head in the Chinese Han population[J]. Cell Mol Biol (Noisy-le-grand), 2017, 63(9): 144. doi: 10.14715/cmb/2017.63.9.23
[20]	ATRETKHANY K S N, DRUTSKAYA M S, NEDOSPASOV S A, et al. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment[J]. Pharmacol Ther, 2016, 168: 98-112. doi: 10.1016/j.pharmthera.2016.09.011
[21]	LEE D K, SONG S U. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications[J]. Cell Immunol, 2018, 326: 68-76. doi: 10.1016/j.cellimm.2017.08.009
[22]	何宜静, 欧琼, 李婷, 等. 过表达NDRG1通过调控VEGF/sFlt-1轴增强缺氧条件下滋养细胞的促血管形成能力[J]. 安徽医科大学学报, 2020, 55(5): 745-750. https://www.cnki.com.cn/Article/CJFDTOTAL-YIKE202005018.htm
[23]	DE HOOGE A S K, VAN DE LOO F A J, KOENDERS M I, et al. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: Exacerbation of joint inflammation in STAT-1 gene-knockout mice[J]. Arthritis Rheum, 2004, 50(6): 2014-2023. doi: 10.1002/art.20302
[24]	ADAPALA N S, YAMAGUCHI R, PHIPPS M, et al. Necrotic bone stimulates proinflammatory responses in macrophages through the activation of toll-like receptor 4[J]. Am J Pathol, 2016, 186(11): 2987-2999. doi: 10.1016/j.ajpath.2016.06.024
[25]	翁艳, 江文锦, 周燕芸. JAK2/STAT3信号通路对激素性股骨头坏死大鼠滑膜组织中细胞因子的影响[J]. 福建医药杂志, 2019, 41(2): 131-134. https://www.cnki.com.cn/Article/CJFDTOTAL-FJYY201902053.htm

[1]	YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
[2]	QIN Suping. Research on levels of C reactive protein and homocysteine in elderly patients with dementia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 56-58. DOI: 10.7619/jcmp.202011015
[3]	CHENG Baoxiang, CAO Lei. Expression characteristics of serum homocysteine and hypersensitive C reactive protein in patients with coronary atherosclerotic heart disease and clinical significance[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 94-97. DOI: 10.7619/jcmp.202006026
[4]	QIU Yuan, LI Li, ZENG Laixing. Changes of C reactive protein and serum procalcitoninin patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 62-64. DOI: 10.7619/jcmp.201912018
[5]	MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
[6]	LIU Li, LIU Mingxin, NIU Shihui, LU Zejun, WANG Nana, ZHANG Ling. Effect of irbesartan combined with atorvastatin on C reactive protein and cystatin C of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2017, (21): 33-35. DOI: 10.7619/jcmp.201721009
[7]	LU Yunnan, HUA Ye, FENG Zhiqiang, MA Tao, HE Peicheng, WU Shuangshuang, XU Hong. Effect of edaravone combined with statins on serum homocysteine, C-reactive protein and lipid levels in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2017, (19): 27-30. DOI: 10.7619/jcmp.201719008
[8]	LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
[9]	SHEN Xin, HU Bingbing. Clinical significance of detecting homocysteine, C-reactive protein and ankle brachial index in elderly patients with lower limb artherosclerosis[J]. Journal of Clinical Medicine in Practice, 2014, (16): 47-49. DOI: 10.7619/jcmp.201416013
[10]	LV Guoling, HUO Zhenglu. Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004

Cited By

Cited by

Periodical cited type(17)

1.	陈海明，杨凯，王华，王德发，郭春华. 补阳还五汤联合针灸康复治疗脑卒中偏瘫的效果及对患者运动功能、生活质量的影响. 大医生. 2025(01): 94-96 .
2.	霍尚飞，葛青叶，罗贺艳，刘敏. 扶正补土针灸联合经颅磁刺激治疗脑卒中后手功能障碍临床研究. 新中医. 2025(02): 118-122 .
3.	王周红，张海玲. 针灸联合康复运动训练治疗脑卒中后偏瘫的效果观察. 中国基层医药. 2025(01): 77-82 .
4.	朱敏. 中医针灸与康复训练结合标准化治疗脑卒中的临床疗效探究. 中国标准化. 2025(04): 321-324 .
5.	张丽苹，龚丹. 通络扶正汤配合针灸辅治缺血性脑卒中后偏瘫痰热瘀阻证临床观察. 实用中医药杂志. 2025(02): 293-295 .
6.	王少儿，王飞，邓艳，陈琼凤. 醒神通经导气针法联合艾灸治疗气虚血瘀型卒中后偏瘫临床研究. 新中医. 2025(05): 151-156 .
7.	赵莉. 头皮针抽提法结合体针治疗脑卒中后肢体功能障碍的临床观察. 实用中西医结合临床. 2025(02): 49-51+94 .
8.	温瑞丽，陈启波，李强，陈丽，古丽红，梁万仟. 扶正补土针灸法联合任务导向性镜像疗法对老年卒中后偏瘫患者上肢功能的影响. 河北中医. 2024(03): 460-463 .
9.	王琨，任静，于文琪，徐大伟，孙慧. 参芪桃花四物汤合复遂汤联合针刺对气虚血瘀证缺血性脑梗死恢复期痉挛性瘫痪患者的临床疗效. 中成药. 2024(06): 1867-1872 .
10.	徐滢，夏源源. 针康法对脑卒中下肢痉挛患者下肢运动功能和肌张力的影响. 现代医学与健康研究电子杂志. 2024(13): 92-94 .
11.	刘莲. 针灸推拿辅治脑卒中后偏瘫临床观察. 实用中医药杂志. 2024(07): 1387-1389 .
12.	胡晓亭. 补阳还五汤配合针灸治疗脑梗死偏瘫患者的效果及影响. 临床研究. 2024(08): 114-117 .
13.	郑伟挺. 血府逐瘀汤加减配合偏瘫肢体康复训练对脑梗死后偏瘫患者神经功能、肢体运动功能的影响分析. 中国现代药物应用. 2024(19): 113-116 .
14.	田亚黎. 旋转对折埋线联合高压氧治疗脑卒中后运动障碍的临床观察. 中国疗养医学. 2024(12): 40-43 .
15.	陈玮琪. 运动疗法联合中医针灸治疗中风后肢体运动功能障碍的效果研究. 内蒙古中医药. 2024(11): 127-128 .
16.	王凡，李朝阳，蒋腾，王山，刘熠. 针刺健侧下肢治疗中风后上肢软瘫的临床研究. 医药论坛杂志. 2024(24): 2677-2680 .
17.	刘文娜，宋霞. 任务导向性训练与扶正补土针灸在脑梗死偏瘫患者康复治疗中的应用效果. 中国卫生标准管理. 2024(23): 160-163 .

Other cited types(0)

Get Citation

PDF

XML

Article views (364) PDF downloads (31) Cited by(17)

Turn off MathJax

Article Contents

Abstract

References

Analysis in mechanism of Taohong Siwu Decoction in the treatment of femoral head necrosis based on network pharmacology